241 related articles for article (PubMed ID: 18362203)
1. Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells.
Oyesanya RA; Lee ZP; Wu J; Chen J; Song Y; Mukherjee A; Dent P; Kordula T; Zhou H; Fang X
FASEB J; 2008 Aug; 22(8):2639-51. PubMed ID: 18362203
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.
He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y
Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C alpha-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2.
Doller A; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
Mol Biol Cell; 2007 Jun; 18(6):2137-48. PubMed ID: 17392515
[TBL] [Abstract][Full Text] [Related]
6. TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR.
Yoo J; Rodriguez Perez CE; Nie W; Sinnett-Smith J; Rozengurt E
BMC Gastroenterol; 2013 May; 13():90. PubMed ID: 23688423
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells.
Cao Z; Liu LZ; Dixon DA; Zheng JZ; Chandran B; Jiang BH
Cell Signal; 2007 Jul; 19(7):1542-53. PubMed ID: 17341442
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells.
Fang X; Yu S; Bast RC; Liu S; Xu HJ; Hu SX; LaPushin R; Claret FX; Aggarwal BB; Lu Y; Mills GB
J Biol Chem; 2004 Mar; 279(10):9653-61. PubMed ID: 14670967
[TBL] [Abstract][Full Text] [Related]
9. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.
Doller A; Akool el-S; Huwiler A; Müller R; Radeke HH; Pfeilschifter J; Eberhardt W
Mol Cell Biol; 2008 Apr; 28(8):2608-25. PubMed ID: 18285462
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.
Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y
Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701
[TBL] [Abstract][Full Text] [Related]
11. Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT.
Fernau NS; Fugmann D; Leyendecker M; Reimann K; Grether-Beck S; Galban S; Ale-Agha N; Krutmann J; Klotz LO
J Biol Chem; 2010 Feb; 285(6):3896-3904. PubMed ID: 19917608
[TBL] [Abstract][Full Text] [Related]
12. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression.
Johann AM; Weigert A; Eberhardt W; Kuhn AM; Barra V; von Knethen A; Pfeilschifter JM; Brüne B
J Immunol; 2008 Jan; 180(2):1239-48. PubMed ID: 18178864
[TBL] [Abstract][Full Text] [Related]
17. Multiple pathways are involved in the anoxia response of SKIP3 including HuR-regulated RNA stability, NF-kappaB and ATF4.
Rzymski T; Paantjens A; Bod J; Harris AL
Oncogene; 2008 Jul; 27(33):4532-43. PubMed ID: 18408768
[TBL] [Abstract][Full Text] [Related]
18. Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.
Woo HH; Yi X; Lamb T; Menzl I; Baker T; Shapiro DJ; Chambers SK
Mol Cell Biol; 2011 Jan; 31(1):215-25. PubMed ID: 20974809
[TBL] [Abstract][Full Text] [Related]
19. Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid.
Oyesanya RA; Greenbaum S; Dang D; Lee Z; Mukherjee A; Wu J; Dent P; Fang X
Mol Cancer; 2010 Jan; 9():8. PubMed ID: 20074357
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-κB Signaling in Bladder Carcinoma Cells.
Khoi PN; Li S; Thuan UT; Sah DK; Kang TW; Nguyen TT; Lian S; Xia Y; Jung YD
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]